Active Ingredient: NAPROXEN
Proprietary Name: EC-NAPROSYN
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 375MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020067
Product Number: 002
Approval Date: Oct 14, 1994
Applicant Holder Full Name: ATNAHS PHARMA US LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
